you are here:

Dr Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE089A01023 | SECTOR: Pharmaceuticals

BSE Live

Apr 13, 16:00
4780.60 -208.60 (-4.18%)
Volume
AVERAGE VOLUME
5-Day
94,905
10-Day
65,854
30-Day
47,191
166,313
  • Prev. Close

    4989.20

  • Open Price

    5200.00

  • Bid Price (Qty.)

    4780.60 (153)

  • Offer Price (Qty.)

    4804.00 (2)

NSE Live

Apr 13, 15:59
4777.30 -219.65 (-4.40%)
Volume
AVERAGE VOLUME
5-Day
2,117,479
10-Day
1,434,845
30-Day
1,112,862
3,937,234
  • Prev. Close

    4996.95

  • Open Price

    5144.70

  • Bid Price (Qty.)

    4777.30 (1179)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2020 2019 2018 2017 2016
Nine Months Results of Dr Reddys Laboratories (in Rs. Cr.) Dec '20 Dec '19 Dec '18 Dec '17 Dec '16  
Net Sales/Income from operations 9,998.40 8,972.70 7,858.30 6,826.00 7,324.70  
Other Operating Income -- 26.00 122.00 41.00 35.00  
Total Income From Operations 9,998.40 8,998.70 7,980.30 6,867.00 7,359.70  
EXPENDITURE  
Consumption of Raw Materials 2,450.00 1,902.20 1,579.90 1,437.00 1,434.60  
Purchase of Traded Goods 925.70 891.10 632.10 457.00 502.90  
Increase/Decrease in Stocks -416.40 -167.10 -40.30 -12.70 -167.20  
Power & Fuel -- -- -- -- --  
Employees Cost 1,724.50 1,513.60 1,441.90 1,379.70 1,431.00  
Depreciation 624.30 596.90 576.40 584.10 545.50  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- 800.70 759.70  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 2,780.70 2,510.10 2,503.60 1,801.80 1,963.90  
P/L Before Other Inc. , Int., Excpt. Items & Tax 1,909.60 1,751.90 1,286.70 419.40 889.30  
Other Income 719.50 615.80 165.70 130.90 533.20  
P/L Before Int., Excpt. Items & Tax 2,629.10 2,367.70 1,452.40 550.30 1,422.50  
Interest 29.80 36.00 48.10 48.70 41.40  
P/L Before Exceptional Items & Tax 2,599.30 2,331.70 1,404.30 501.60 1,381.10  
Exceptional Items -- -- -- -- --  
P/L Before Tax 2,599.30 2,331.70 1,404.30 501.60 1,381.10  
Tax 724.40 -103.20 329.80 111.30 220.00  
P/L After Tax from Ordinary Activities 1,874.90 2,434.90 1,074.50 390.30 1,161.10  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 1,874.90 2,434.90 1,074.50 390.30 1,161.10  
Equity Share Capital 83.10 83.10 83.00 82.90 82.90  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 113.05 146.89 64.75 23.54 69.55  
Diluted EPS 112.73 146.62 64.67 23.49 69.38  
EPS After Extra Ordinary  
Basic EPS. 113.05 146.89 64.75 23.54 69.55  
Diluted EPS. 112.73 146.62 64.67 23.49 69.38  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
Source : Dion Global Solutions Limited

Results of Dr Reddys Labs